Clinical Trial Update: A Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating CT-P51 versus pembrolizumab (Keytruda) in patients with previously untreated metastatic non-small cell lung cancer is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CT-P51
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Celltrion | Conditions: Non Squamous Non Small Cell Lung Cancer | Phase 3 | Status: RECRUITING